Recombinant Human LYG2 protein (His tag N-Terminus)

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

LYG2 also known as Lysosomal Glycoprotein 2 is a protein with a mass of approximately 55 kDa. It plays a mechanical role in the degradation of glycoproteins within the lysosome. Expressed mainly in the kidney liver and spleen LYG2 functions as an important component of the lysosomal membrane helping to regulate the cellular process of autophagy and degradation of complex molecules. Its alternate name GP50 refers to its glycosylated nature which is important for its stability and interaction with other molecules in the lysosome.

Biological function summary

LYG2 interacts with lysosomal hydrolases to facilitate the breakdown of glycoproteins impacting cellular metabolism and waste processing. It acts as part of a multi-protein complex within the lysosome which is essential for maintaining intracellular homeostasis. By contributing to the lysosomal function LYG2 supports efficient recycling of cellular components and influences processes linked to cellular growth and energy supply.

Pathways

LYG2 participates in lysosomal degradation pathways which are integral to autophagy and the recycling of cellular materials. These pathways intersect with the endocytic pathway sharing roles with proteins such as LAMP1 and LAMP2 which are also involved in lysosomal function. LYG2's role in these pathways highlights its interconnectedness with cellular catabolic processes and its importance in maintaining cellular nutrient balance.

Dysregulation of LYG2 activity is connected to metabolic and lysosomal storage disorders. Alterations in LYG2 expression or function are linked with conditions like mucolipidosis where lysosomal storage is impaired. In such disorders LYG2 often interacts with proteins like NPC1 reflecting its role in the proper trafficking and degradation of glycoproteins within cells. Understanding LYG2's role in these diseases can help guide therapeutic strategies aimed at correcting lysosomal dysfunction.